Search
Leader | 00000nz a2200037n 45 0 | ||
---|---|---|---|
001 | WKP|Q83900113 (VIAF cluster) (Authority/Source Record) | ||
003 | WKP | ||
005 | 20241221010857.0 | ||
008 | 241221nneanz||abbn n and d | ||
035 | ‡a (WKP)Q83900113 | ||
024 | ‡a 0000-0002-7634-6812 ‡2 orcid | ||
024 | ‡a 55450211700 ‡2 scopus | ||
035 | ‡a (OCoLC)Q83900113 | ||
100 | 0 | ‡a Jan Nielsen ‡9 da | |
400 | 0 | ‡a Jan Nielsen ‡c researcher ‡9 en | |
400 | 0 | ‡a J Nielsen ‡c wetenschapper ‡9 nl | |
670 | ‡a Author's Analyzing multivariate survival data using composite likelihood and flexible parametric modeling of the hazard functions. | ||
670 | ‡a Author's Anti-TNF-α Use During the Third Trimester of Pregnancy in Women with Moderate-severe Inflammatory Bowel Disease and the Risk of Preterm Birth and Low Birth Weight | ||
670 | ‡a Author's Can family history and cord blood IgE predict sensitization and allergic diseases up to adulthood? | ||
670 | ‡a Author's Comparison of Time to Pregnancy in Women With and Without Inflammatory Bowel Diseases | ||
670 | ‡a Author's Diagnosis of preeclampsia with soluble Fms-like tyrosine kinase 1/placental growth factor ratio: an inter-assay comparison | ||
670 | ‡a Author's Early pregnancy angiogenic markers and spontaneous abortion: an Odense Child Cohort study | ||
670 | ‡a Author's Editorial: anti-TNF therapy-a double-edged sword? Authors' reply | ||
670 | ‡a Author's Fecal Calprotectin During Pregnancy in Women With Moderate-Severe Inflammatory Bowel Disease. | ||
670 | ‡a Author's Heritability of clubfoot: a twin study | ||
670 | ‡a Author's In utero exposure to thiopurines/anti-TNF agents and long-term health outcomes during childhood and adolescence in Denmark | ||
670 | ‡a Author's Increased risk of developing Crohn's disease or ulcerative colitis in 17 018 patients while under treatment with anti-TNFα agents, particularly etanercept, for autoimmune diseases other than inflammatory bowel disease | ||
670 | ‡a Author's Letter: number of treatments with anti-TNF-α and reoperations in inflammatory bowel disease. | ||
670 | ‡a Author's Paternal use of medications for inflammatory bowel disease and the risk of hospital‐diagnosed infections in the offspring: a nationwide cohort study | ||
670 | ‡a Author's Patients with inflammatory bowel disease have increased risk of autoimmune and inflammatory diseases. | ||
670 | ‡a Author's Postoperative Use of Anti-TNF-α Agents in Patients with Crohn's Disease and Risk of Reoperation-A Nationwide Cohort Study. | ||
670 | ‡a Author's Pre-operative use of anti-TNF-α agents and the risk of post-operative complications in patients with Crohn's disease--a nationwide cohort study. | ||
670 | ‡a Author's Pre-operative use of anti-TNF-α agents and the risk of post-operative complications in patients with ulcerative colitis - a nationwide cohort study. | ||
670 | ‡a Author's Prediction of preeclampsia with angiogenic biomarkers. Results from the prospective Odense Child Cohort. | ||
670 | ‡a Author's Reply: To PMID 25420698 | ||
670 | ‡a Author's Risk factors and between-hospital variation of caesarean section in Denmark: a cohort study. | ||
670 | ‡a Author's S-25-hydroxyvitamin D and C3-epimers in pregnancy and infancy: An Odense Child Cohort study. | ||
670 | ‡a Author's Sexual health in women with inflammatory bowel disease in the Danish National Birth Cohort | ||
670 | ‡a Author's The Danish Neuro-Oncology Registry: establishment, completeness and validity. | ||
670 | ‡a Author's The Effect of Disease Activity on Birth Outcomes in a Nationwide Cohort of Women with Moderate to Severe Inflammatory Bowel Disease. | ||
670 | ‡a Author's The incidence of ulcerative colitis (1995-2011) and Crohn's disease (1995-2012) - based on nationwide Danish registry data | ||
670 | ‡a Author's The natural course of sensitization and allergic diseases from childhood to adulthood. | ||
670 | ‡a Author's Vitamin D insufficiency is associated with increased risk of first-trimester miscarriage in the Odense Child Cohort. | ||
670 | ‡a Author's Vitamin D supplementation, cord 25-hydroxyvitamin D and birth weight: Findings from the Odense Child Cohort. | ||
909 | ‡a (orcid) 0000000276346812 ‡9 1 | ||
909 | ‡a (scopus) 55450211700 ‡9 1 | ||
919 | ‡a s25hydroxyvitamin500andc3epimersinpregnancyandinfancyanodensechildcohortstudy ‡A S-25-hydroxyvitamin D and C3-epimers in pregnancy and infancy: An Odense Child Cohort study. ‡9 1 | ||
919 | ‡a sexualhealthinwomenwithinflammatoryboweldiseaseinthedanishnationalbirthcohort ‡A Sexual health in women with inflammatory bowel disease in the Danish National Birth Cohort ‡9 1 | ||
919 | ‡a vitamin500supplementationcord25hydroxyvitamin500andbirthweightfindingsfromtheodensechildcohort ‡A Vitamin D supplementation, cord 25-hydroxyvitamin D and birth weight: Findings from the Odense Child Cohort. ‡9 1 | ||
919 | ‡a analyzingmultivariatesurvivaldatausingcompositelikelihoodandflexibleparametricmodelingofthehazardfunctions ‡A Analyzing multivariate survival data using composite likelihood and flexible parametric modeling of the hazard functions. ‡9 1 | ||
919 | ‡a antitnfαuseduringthe3trimesterofpregnancyinwomenwithmoderatesevereinflammatoryboweldiseaseandtheriskofpretermbirthandlowbirthweight ‡A Anti-TNF-α Use During the Third Trimester of Pregnancy in Women with Moderate-severe Inflammatory Bowel Disease and the Risk of Preterm Birth and Low Birth Weight ‡9 1 | ||
919 | ‡a canfamilyhistoryandcordbloodigepredictsensitizationandallergicdiseasesuptoadulthood ‡A Can family history and cord blood IgE predict sensitization and allergic diseases up to adulthood? ‡9 1 | ||
919 | ‡a comparisonoftimetopregnancyinwomenwithandwithoutinflammatoryboweldiseases ‡A Comparison of Time to Pregnancy in Women With and Without Inflammatory Bowel Diseases ‡9 1 | ||
919 | ‡a diagnosisofpreeclampsiawithsolublefmsliketyrosinekinase1placentalgrowthfactorratioaninterassaycomparison ‡A Diagnosis of preeclampsia with soluble Fms-like tyrosine kinase 1/placental growth factor ratio: an inter-assay comparison ‡9 1 | ||
919 | ‡a earlypregnancyangiogenicmarkersandspontaneousabortionanodensechildcohortstudy ‡A Early pregnancy angiogenic markers and spontaneous abortion: an Odense Child Cohort study ‡9 1 | ||
919 | ‡a editorialantitnftherapyadoubleedgedswordauthorsreply ‡A Editorial: anti-TNF therapy-a double-edged sword? Authors' reply ‡9 1 | ||
919 | ‡a fecalcalprotectinduringpregnancyinwomenwithmoderatesevereinflammatoryboweldisease ‡A Fecal Calprotectin During Pregnancy in Women With Moderate-Severe Inflammatory Bowel Disease. ‡9 1 | ||
919 | ‡a vitamin500insufficiencyisassociatedwithincreasedriskof1trimestermiscarriageintheodensechildcohort ‡A Vitamin D insufficiency is associated with increased risk of first-trimester miscarriage in the Odense Child Cohort. ‡9 1 | ||
919 | ‡a naturalcourseofsensitizationandallergicdiseasesfromchildhoodtoadulthood ‡A The natural course of sensitization and allergic diseases from childhood to adulthood. ‡9 1 | ||
919 | ‡a incidenceofulcerativecolitis19952011andcrohnsdisease19952012basedonnationwidedanishregistrydata ‡A The incidence of ulcerative colitis (1995-2011) and Crohn's disease (1995-2012) - based on nationwide Danish registry data ‡9 1 | ||
919 | ‡a effectofdiseaseactivityonbirthoutcomesinanationwidecohortofwomenwithmoderatetosevereinflammatoryboweldisease ‡A The Effect of Disease Activity on Birth Outcomes in a Nationwide Cohort of Women with Moderate to Severe Inflammatory Bowel Disease. ‡9 1 | ||
919 | ‡a danishneurooncologyregistryestablishmentcompletenessandvalidity ‡A The Danish Neuro-Oncology Registry: establishment, completeness and validity. ‡9 1 | ||
919 | ‡a heritabilityofclubfootatwinstudy ‡A Heritability of clubfoot: a twin study ‡9 1 | ||
919 | ‡a inuteroexposuretothiopurinesantitnfagentsandlongtermhealthoutcomesduringchildhoodandadolescenceindenmark ‡A In utero exposure to thiopurines/anti-TNF agents and long-term health outcomes during childhood and adolescence in Denmark ‡9 1 | ||
919 | ‡a increasedriskofdevelopingcrohnsdiseaseorulcerativecolitisin17018patientswhileundertreatmentwithantitnfαagentsparticularlyetanerceptforautoimmunediseasesotherthaninflammatoryboweldisease ‡A Increased risk of developing Crohn's disease or ulcerative colitis in 17 018 patients while under treatment with anti-TNFα agents, particularly etanercept, for autoimmune diseases other than inflammatory bowel disease ‡9 1 | ||
919 | ‡a letternumberoftreatmentswithantitnfαandreoperationsininflammatoryboweldisease ‡A Letter: number of treatments with anti-TNF-α and reoperations in inflammatory bowel disease. ‡9 1 | ||
919 | ‡a paternaluseofmedicationsforinflammatoryboweldiseaseandtheriskofhospitaldiagnosedinfectionsintheoffspringanationwidecohortstudy ‡A Paternal use of medications for inflammatory bowel disease and the risk of hospital‐diagnosed infections in the offspring: a nationwide cohort study ‡9 1 | ||
919 | ‡a patientswithinflammatoryboweldiseasehaveincreasedriskofautoimmuneandinflammatorydiseases ‡A Patients with inflammatory bowel disease have increased risk of autoimmune and inflammatory diseases. ‡9 1 | ||
919 | ‡a postoperativeuseofantitnfαagentsinpatientswithcrohnsdiseaseandriskofreoperationanationwidecohortstudy ‡A Postoperative Use of Anti-TNF-α Agents in Patients with Crohn's Disease and Risk of Reoperation-A Nationwide Cohort Study. ‡9 1 | ||
919 | ‡a preoperativeuseofantitnfαagentsandtheriskofpostoperativecomplicationsinpatientswithcrohnsdiseaseanationwidecohortstudy ‡A Pre-operative use of anti-TNF-α agents and the risk of post-operative complications in patients with Crohn's disease--a nationwide cohort study. ‡9 1 | ||
919 | ‡a preoperativeuseofantitnfαagentsandtheriskofpostoperativecomplicationsinpatientswithulcerativecolitisanationwidecohortstudy ‡A Pre-operative use of anti-TNF-α agents and the risk of post-operative complications in patients with ulcerative colitis - a nationwide cohort study. ‡9 1 | ||
919 | ‡a predictionofpreeclampsiawithangiogenicbiomarkersresultsfromtheprospectiveodensechildcohort ‡A Prediction of preeclampsia with angiogenic biomarkers. Results from the prospective Odense Child Cohort. ‡9 1 | ||
919 | ‡a replytopmid25420698 ‡A Reply: To PMID 25420698 ‡9 1 | ||
919 | ‡a riskfactorsandbetweenhospitalvariationofcaesareansectionindenmarkacohortstudy ‡A Risk factors and between-hospital variation of caesarean section in Denmark: a cohort study. ‡9 1 | ||
996 | ‡2 DBC|87097968773245 | ||
996 | ‡2 DBC|87097968082781 | ||
996 | ‡2 LC|n 80038040 | ||
996 | ‡2 W2Z|7053342 | ||
996 | ‡2 ISNI|0000000429290531 | ||
996 | ‡2 ISNI|0000000500939787 | ||
996 | ‡2 W2Z|1492758307957 | ||
996 | ‡2 DBC|87097968420482 | ||
996 | ‡2 DBC|87097968715776 | ||
996 | ‡2 DBC|87097968760437 | ||
996 | ‡2 DNB|124721737 | ||
996 | ‡2 LC|n 2002035331 | ||
996 | ‡2 BIBSYS|90271608 | ||
996 | ‡2 ISNI|0000000024499695 | ||
996 | ‡2 LC|n 2013036480 | ||
996 | ‡2 DBC|870979136854305 | ||
996 | ‡2 BIBSYS|90091394 | ||
996 | ‡2 SELIBR|408595 | ||
996 | ‡2 JPG|500075353 | ||
996 | ‡2 LC|n 2015184221 | ||
996 | ‡2 ISNI|0000000024430743 | ||
996 | ‡2 DBC|870979137756455 | ||
996 | ‡2 PLWABN|9810667477605606 | ||
996 | ‡2 DBC|87097962215518 | ||
996 | ‡2 DNB|1056093455 | ||
996 | ‡2 DNB|1055701680 | ||
996 | ‡2 BIBSYS|90982783 | ||
996 | ‡2 DBC|870979137674793 | ||
996 | ‡2 ISNI|0000000060585013 | ||
996 | ‡2 DBC|87097991690799 | ||
996 | ‡2 DBC|87097947123135 | ||
996 | ‡2 DBC|87097991020726 | ||
996 | ‡2 DBC|87097919179753 | ||
996 | ‡2 W2Z|90293315 | ||
996 | ‡2 ISNI|0000000035994229 | ||
996 | ‡2 ISNI|0000000383691726 | ||
996 | ‡2 BIBSYS|90932622 | ||
996 | ‡2 DBC|870979138358917 | ||
996 | ‡2 BNF|16745998 | ||
996 | ‡2 RERO|A026092966 | ||
996 | ‡2 DBC|87097968529085 | ||
996 | ‡2 DBC|87097961957863 | ||
996 | ‡2 DBC|87097991295180 | ||
996 | ‡2 DBC|87097946471628 | ||
996 | ‡2 BIBSYS|14060256 | ||
996 | ‡2 BIBSYS|90964384 | ||
996 | ‡2 BIBSYS|1523352732218 | ||
996 | ‡2 DNB|105191437X | ||
996 | ‡2 NKC|xx0130533 | ||
996 | ‡2 DBC|87097919179761 | ||
996 | ‡2 DBC|87097968872014 | ||
996 | ‡2 LC|no2024093081 | ||
996 | ‡2 BIBSYS|90511811 | ||
996 | ‡2 DBC|87097969055281 | ||
996 | ‡2 DNB|171843932 | ||
996 | ‡2 BIBSYS|13009498 | ||
996 | ‡2 ISNI|0000000026523572 | ||
996 | ‡2 BIBSYS|90660546 | ||
996 | ‡2 BIBSYS|1642068439113 | ||
996 | ‡2 BIBSYS|1642068439114 | ||
996 | ‡2 BIBSYS|1642068439115 | ||
996 | ‡2 BIBSYS|1642068439116 | ||
996 | ‡2 BNCHL|10000000000000000175231 | ||
996 | ‡2 DNB|1158007183 | ||
996 | ‡2 W2Z|9008264 | ||
996 | ‡2 DNB|1135672695 | ||
996 | ‡2 DBC|87097968749468 | ||
996 | ‡2 W2Z|3109811 | ||
996 | ‡2 BIBSYS|7053342 | ||
996 | ‡2 W2Z|1523352732218 | ||
996 | ‡2 BIBSYS|12026058 | ||
996 | ‡2 DBC|87097968172365 | ||
996 | ‡2 ISNI|0000000391929167 | ||
996 | ‡2 ISNI|000000002984905X | ||
996 | ‡2 BNF|12529192 | ||
996 | ‡2 DBC|87097968715741 | ||
996 | ‡2 ISNI|0000000042526191 | ||
996 | ‡2 ISNI|0000000488652416 | ||
996 | ‡2 SUDOC|166618233 | ||
996 | ‡2 DBC|87097991279924 | ||
996 | ‡2 DNB|1155328841 | ||
996 | ‡2 ISNI|0000000065689604 | ||
996 | ‡2 BIBSYS|90211583 | ||
996 | ‡2 W2Z|11046794 | ||
996 | ‡2 ISNI|0000000488608431 | ||
996 | ‡2 NTA|237179202 | ||
996 | ‡2 DBC|87097919452514 | ||
996 | ‡2 BIBSYS|99034136 | ||
996 | ‡2 BIBSYS|1055705 | ||
996 | ‡2 ISNI|0000000021440137 | ||
996 | ‡2 W2Z|90091394 | ||
996 | ‡2 LC|no2022058150 | ||
996 | ‡2 LC|n 2009028058 | ||
996 | ‡2 BIBSYS|6097897 | ||
996 | ‡2 DBC|87097991690764 | ||
996 | ‡2 DBC|87097968977789 | ||
996 | ‡2 BIBSYS|14070371 | ||
996 | ‡2 LC|n 2024063641 | ||
996 | ‡2 DBC|87097968750326 | ||
996 | ‡2 BIBSYS|5029931 | ||
996 | ‡2 NTA|400882035 | ||
996 | ‡2 SUDOC|224431145 | ||
996 | ‡2 RERO|A008836016 | ||
996 | ‡2 DBC|87097969098886 | ||
996 | ‡2 DBC|87097946844645 | ||
996 | ‡2 BIBSYS|14045830 | ||
996 | ‡2 LC|n 97051602 | ||
996 | ‡2 ISNI|0000000025693326 | ||
996 | ‡2 DNB|1157194788 | ||
996 | ‡2 BNF|12152469 | ||
996 | ‡2 DNB|1037624246 | ||
996 | ‡2 DBC|87097968749565 | ||
996 | ‡2 NUKAT|n 2015156229 | ||
996 | ‡2 DBC|87097968469600 | ||
996 | ‡2 DNB|1158265530 | ||
996 | ‡2 DNB|1171352476 | ||
996 | ‡2 DBC|87097947766184 | ||
996 | ‡2 BIBSYS|14029645 | ||
996 | ‡2 DBC|87097968749581 | ||
996 | ‡2 DBC|87097939578689 | ||
996 | ‡2 DBC|87097968749425 | ||
996 | ‡2 W2Z|1642068439113 | ||
996 | ‡2 W2Z|1642068439116 | ||
996 | ‡2 W2Z|1642068439117 | ||
996 | ‡2 DBC|87097968568315 | ||
996 | ‡2 W2Z|1642068439115 | ||
996 | ‡2 DBC|87097991690896 | ||
996 | ‡2 DBC|87097991690950 | ||
996 | ‡2 PLWABN|9810668436105606 | ||
996 | ‡2 UIY|000040849 | ||
996 | ‡2 ISNI|0000000361411121 | ||
996 | ‡2 DBC|87097968129427 | ||
996 | ‡2 SUDOC|177089733 | ||
996 | ‡2 ISNI|0000000485887359 | ||
996 | ‡2 DNB|1062407091 | ||
996 | ‡2 LC|n 2005027479 | ||
996 | ‡2 DBC|87097990498169 | ||
996 | ‡2 DBC|87097968762138 | ||
996 | ‡2 NII|DA06267896 | ||
996 | ‡2 DBC|87097947673259 | ||
996 | ‡2 LC|n 80028369 | ||
996 | ‡2 DBC|87097992288927 | ||
996 | ‡2 LC|n 92072635 | ||
996 | ‡2 DBC|87097991690608 | ||
996 | ‡2 J9U|987007267610905171 | ||
996 | ‡2 CAOONL|ncf11573596 | ||
996 | ‡2 BIBSYS|9008264 | ||
996 | ‡2 DNB|1089096755 | ||
996 | ‡2 DNB|1165103400 | ||
996 | ‡2 DBC|87097968815606 | ||
996 | ‡2 LC|n 82074691 | ||
996 | ‡2 DBC|870979135511773 | ||
996 | ‡2 BIBSYS|90291028 | ||
996 | ‡2 BIBSYS|90259967 | ||
996 | ‡2 DNB|1024975185 | ||
996 | ‡2 DBC|87097968680093 | ||
996 | ‡2 ISNI|0000000037826819 | ||
996 | ‡2 NTA|40234670X | ||
996 | ‡2 BIBSYS|90298550 | ||
996 | ‡2 DBC|87097968902703 | ||
996 | ‡2 CAOONL|ncf13739220 | ||
996 | ‡2 SUDOC|079405983 | ||
996 | ‡2 BIBSYS|7078326 | ||
996 | ‡2 DBC|87097968045444 | ||
996 | ‡2 NTA|290678528 | ||
996 | ‡2 DBC|87097969375618 | ||
996 | ‡2 DBC|87097968359880 | ||
996 | ‡2 BIBSYS|90943757 | ||
996 | ‡2 W2Z|90773557 | ||
996 | ‡2 CAOONL|ncf11207401 | ||
996 | ‡2 BIBSYS|90263670 | ||
996 | ‡2 LC|nb2021001468 | ||
996 | ‡2 ISNI|0000000025038364 | ||
996 | ‡2 NTA|12826876X | ||
996 | ‡2 NTA|180480480 | ||
996 | ‡2 DBC|87097968749433 | ||
996 | ‡2 DBC|87097968750318 | ||
996 | ‡2 DNB|1211979997 | ||
996 | ‡2 DBC|87097968871174 | ||
996 | ‡2 CAOONL|ncf10255497 | ||
996 | ‡2 LC|n 2012025527 | ||
996 | ‡2 BIBSYS|3063730 | ||
996 | ‡2 SZ|1223034984 | ||
996 | ‡2 ISNI|0000000107854664 | ||
996 | ‡2 ISNI|0000000429112452 | ||
996 | ‡2 DBC|87097991694174 | ||
996 | ‡2 BIBSYS|3025014 | ||
996 | ‡2 W2Z|9047270 | ||
996 | ‡2 ISNI|0000000384839470 | ||
996 | ‡2 ISNI|0000000075447211 | ||
996 | ‡2 LC|no2009033688 | ||
996 | ‡2 LC|n 81041053 | ||
996 | ‡2 LC|n 85252682 | ||
996 | ‡2 SUDOC|034547142 | ||
996 | ‡2 BIBSYS|90859992 | ||
996 | ‡2 BIBSYS|15016070 | ||
996 | ‡2 ISNI|0000000020360151 | ||
996 | ‡2 ISNI|0000000109054783 | ||
996 | ‡2 JPG|500074780 | ||
996 | ‡2 LC|n 79105174 | ||
996 | ‡2 DBC|87097946291212 | ||
996 | ‡2 DNB|1157182917 | ||
996 | ‡2 LC|no2006104938 | ||
996 | ‡2 ISNI|0000000410202773 | ||
996 | ‡2 BIBSYS|90773557 | ||
996 | ‡2 ISNI|000000038449429X | ||
996 | ‡2 DBC|87097968749603 | ||
996 | ‡2 DBC|87097946453328 | ||
996 | ‡2 ISNI|0000000449601923 | ||
996 | ‡2 LC|n 80036338 | ||
996 | ‡2 DBC|87097991690918 | ||
996 | ‡2 DBC|87097991687658 | ||
996 | ‡2 BAV|495_164421 | ||
996 | ‡2 DBC|87097919025535 | ||
996 | ‡2 W2Z|14029645 | ||
996 | ‡2 NSK|000164777 | ||
996 | ‡2 NUKAT|n 2019004627 | ||
996 | ‡2 BIBSYS|67318 | ||
996 | ‡2 LC|n 79009185 | ||
996 | ‡2 DBC|87097991763710 | ||
996 | ‡2 NII|DA10198017 | ||
996 | ‡2 RERO|A003640679 | ||
996 | ‡2 RERO|A003640678 | ||
996 | ‡2 BIBSYS|90711223 | ||
996 | ‡2 BIBSYS|4066942 | ||
996 | ‡2 DNB|1324331232 | ||
996 | ‡2 DBC|87097991690772 | ||
996 | ‡2 DBC|87097946896033 | ||
996 | ‡2 DBC|87097969467067 | ||
996 | ‡2 RERO|A027721256 | ||
996 | ‡2 BIBSYS|1492758307957 | ||
996 | ‡2 ISNI|0000000485953774 | ||
996 | ‡2 DNB|1223034984 | ||
996 | ‡2 DBC|87097919213234 | ||
996 | ‡2 BIBSYS|2005849 | ||
996 | ‡2 DBC|87097961814906 | ||
996 | ‡2 NII|DA12425492 | ||
996 | ‡2 LC|no 99004327 | ||
996 | ‡2 LC|n 2012038911 | ||
996 | ‡2 DBC|87097968749557 | ||
996 | ‡2 ISNI|0000000369468894 | ||
996 | ‡2 BIBSYS|1006623 | ||
996 | ‡2 DBC|87097990317261 | ||
996 | ‡2 LC|n 2020040137 | ||
996 | ‡2 DBC|87097991694433 | ||
996 | ‡2 DBC|87097968073723 | ||
996 | ‡2 DBC|87097968750776 | ||
996 | ‡2 DBC|87097991690888 | ||
996 | ‡2 DBC|87097919456730 | ||
996 | ‡2 LC|n 2003055183 | ||
997 | ‡a 0 0 lived 0 0 ‡9 1 |